Drug: medroxyprogesterone Quarter: 2016Q3
Total Records: 88 Number of Pages: 5
| DRUGNAME | PT | EventCount |
|---|---|---|
| MEDROXYPROGESTERONE | Paraesthesia | 1 |
| MEDROXYPROGESTERONE | Product odour abnormal | 1 |
| MEDROXYPROGESTERONE | Renal disorder | 1 |
| MEDROXYPROGESTERONE | Skin disorder | 1 |
| MEDROXYPROGESTERONE | Vision blurred | 1 |
| MEDROXYPROGESTERONE ACETATE 150MG/1ML | Myocardial infarction | 1 |
| MEDROXYPROGESTERONE ACETATE 150MG/1ML | Thrombosis | 1 |
| MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE | Product name confusion | 1 |
| MEDROXYPROGESTERONE ACETATE, 150MG PER ML | Product expiration date issue | 1 |
| MEDROXYPROGESTERONE ACETATE, 150MG PER ML | Product measured potency issue | 1 |
| MEDROXYPROGESTERONE ACETATE. | Abdominal discomfort | 1 |
| MEDROXYPROGESTERONE ACETATE. | Abdominal pain | 1 |
| MEDROXYPROGESTERONE ACETATE. | Activities of daily living impaired | 1 |
| MEDROXYPROGESTERONE ACETATE. | Amenorrhoea | 1 |
| MEDROXYPROGESTERONE ACETATE. | Asthenia | 1 |
| MEDROXYPROGESTERONE ACETATE. | Back pain | 1 |
| MEDROXYPROGESTERONE ACETATE. | Blood creatinine increased | 1 |
| MEDROXYPROGESTERONE ACETATE. | Coma | 1 |
| MEDROXYPROGESTERONE ACETATE. | Coma scale abnormal | 1 |
| MEDROXYPROGESTERONE ACETATE. | Confusional state | 1 |
Total Records: 88 Number of Pages: 5